Diversity and evolution of class 2 CRISPR-Cas systems

Nature Reviews Microbiology

Volumn 15, Issue 3, 2017, Pages 169-182

  Shmakov, Sergey ^a,b   Smargon, Aaron ^c,d   Scott, David ^c   Cox, David ^c   Pyzocha, Neena ^c,e   Yan, Winston ^c   Abudayyeh, Omar O ^c,e   Gootenberg, Jonathan S ^c,f   Makarova, Kira S ^b   Wolf, Yuri I ^b   Severinov, Konstantin ^a,g,h   Zhang, Feng ^c,e,f,i   Koonin, Eugene V ^b  

^a SKOLKOVO INSTITUTE OF SCIENCE AND TECHNOLOGY   (Russian Federation)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d USA   (United States)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^f MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^g RUTGERS UNIVERSITY   (United States)

^h INSTITUTE OF MOLECULAR GENETICS   (Russian Federation)

ⁱ Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARCHAEAL GENOME; ARTICLE; BACTERIAL GENOME; CRISPR CAS SYSTEM; GENE LOCUS; GENE NOMENCLATURE; GENETIC ENGINEERING; GENETIC IDENTIFICATION; GENETIC VARIABILITY; GENOMICS; MICROBIAL DIVERSITY; MOLECULAR EVOLUTION; NONHUMAN; PRIORITY JOURNAL; ARCHAEON; BACTERIUM; GENE EDITING; GENETICS; PROCEDURES; PROTEIN DOMAIN;

CRISPR ASSOCIATED PROTEIN;

ARCHAEA; BACTERIA; CRISPR-ASSOCIATED PROTEINS; CRISPR-CAS SYSTEMS; GENE EDITING; GENOME, ARCHAEAL; GENOME, BACTERIAL; PROTEIN DOMAINS;

EID: 85010207605     PISSN: 17401526     EISSN: 17401534     Source Type: Journal    
DOI: 10.1038/nrmicro.2016.184     Document Type: Article

References (80)

1. Makarova, K. S., Grishin, N. V., Shabalina, S. A., Wolf, Y. I. & Koonin, E. V. A putative RNA-interferencebased immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action. Biol. Direct 1, 7 (2006).
2. Barrangou, R. et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science 315, 1709-1712 (2007).
3. Barrangou, R. CRISPR-Cas systems and RNA-guided interference. Wiley Interdiscip. Rev. RNA 4, 267-278 (2013).
4. Marraffini, L. A. CRISPR-Cas immunity in prokaryotes. Nature 526, 55-61 (2015).
5. Mohanraju, P. et al. Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems. Science 353, aad5147 (2016).
6. Van der Oost, J., Westra, E. R., Jackson, R. N. & Wiedenheft, B. Unravelling the structural and mechanistic basis of CRISPR-Cas systems. Nat. Rev. Microbiol. 12, 479-492 (2014).
7. Makarova, K. S., Aravind, L., Wolf, Y. I. & Koonin, E. V. Unification of Cas protein families and a simple scenario for the origin and evolution of CRISPR-Cas systems. Biol. Direct 6, 38 (2011).
8. Makarova, K. S., Wolf, Y. I. & Koonin, E. V. The basic building blocks and evolution of CRISPR-Cas systems. Biochem. Soc. Trans. 41, 1392-1400 (2013).
9. Takeuchi, N., Wolf, Y. I., Makarova, K. S. & Koonin, E. V. Nature and intensity of selection pressure on CRISPR-associated genes. J. Bacteriol. 194, 1216-1225 (2012).
10. Bondy-Denomy, J. & Davidson, A. R. To acquire or resist: the complex biological effects of CRISPR-Cas systems. Trends Microbiol. 22, 218-225 (2014).
11. Bondy-Denomy, J. et al. Multiple mechanisms for CRISPR-Cas inhibition by anti-CRISPR proteins. Nature 526, 136-139 (2015).
12. van Houte, S. et al. The diversity-generating benefits of a prokaryotic adaptive immune system. Nature 532, 385-388 (2016).
13. Makarova, K. S. et al. Evolution and classification of the CRISPR-Cas systems. Nat. Rev. Microbiol. 9, 467-477 (2011).
14. Makarova, K. S. & Koonin, E. V. Annotation and classification of CRISPR-Cas systems. Methods Mol. Biol. 1311, 47-75 (2015).
15. Makarova, K. S. et al. An updated evolutionary classification of CRISPR-Cas systems. Nat. Rev. Microbiol. 13, 722-736 (2015).
16. Shmakov, S. et al. Discovery and functional characterization of diverse class 2 CRISPR-Cas systems. Mol. Cell 60, 385-397 (2015).
17. Chylinski, K., Makarova, K. S., Charpentier, E. & Koonin, E. V. Classification and evolution of type II CRISPR-Cas systems. Nucleic Acids Res. 42, 6091-6105 (2014).
18. Brouns, S. J. et al. Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 321, 960-964 (2008).
19. Jore, M. M. et al. Structural basis for CRISPR RNAguided DNA recognition by Cascade. Nat. Struct. Mol. Biol. 18, 529-536 (2011).
20. Beloglazova, N. et al. CRISPR RNA binding and DNA target recognition by purified Cascade complexes from Escherichia coli. Nucleic Acids Res. 43, 530-543 (2015).
21. Jackson, R. N. et al. Structural biology. Crystal structure of the CRISPR RNA-guided surveillance complex from Escherichia coli. Science 345, 1473-1479 (2014).
22. Rouillon, C. et al. Structure of the CRISPR interference complex CSM reveals key similarities with cascade. Mol. Cell 52, 124-134 (2013).
23. Staals, R. H. et al. RNA targeting by the type III?A CRISPR-Cas Csm complex of Thermus thermophilus. Mol. Cell 56, 518-530 (2014).
24. Osawa, T., Inanaga, H., Sato, C. & Numata, T. Crystal structure of the CRISPR-Cas RNA silencing Cmr complex bound to a target analog. Mol. Cell 58, 418-430 (2015).
25. Taylor, D. W. et al. Structural biology. Structures of the CRISPR-Cmr complex reveal mode of RNA target positioning. Science 348, 581-585 (2015).
26. Jinek, M. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816-821 (2012).
27. Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819-823 (2013).
28. Mali, P., Esvelt, K. M. & Church, G. M. Cas9 as a versatile tool for engineering biology. Nat. Methods 10, 957-963 (2013).
29. Gasiunas, G., Barrangou, R., Horvath, P. & Siksnys, V. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc. Natl Acad. Sci. USA 109, E2579-E2586 (2012).
30. Nishimasu, H. et al. Crystal structure of Cas9 in complex with guide RNA and target DNA. Cell 156, 935-949 (2014).
31. Nishimasu, H. et al. Crystal structure of Staphylococcus aureus Cas9. Cell 162, 1113-1126 (2015).
32. Sternberg, S. H., LaFrance, B., Kaplan, M. & Doudna, J. A. Conformational control of DNA target cleavage by CRISPR-Cas9. Nature 527, 110-113 (2015).
33. Sapranauskas, R. et al. The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli. Nucleic Acids Res. 39, 9275-9282 (2011).
34. Deltcheva, E. et al. CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471, 602-607 (2011).
35. Chylinski, K., Le Rhun, A. & Charpentier, E. The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems. RNA Biol. 10, 726-737 (2013).
36. Briner, A. E. et al. Guide RNA functional modules direct Cas9 activity and orthogonality. Mol. Cell 56, 333-339 (2014).
37. Schunder, E., Rydzewski, K., Grunow, R. & Heuner, K. First indication for a functional CRISPR/Cas system in Francisella tularensis. Int. J. Med. Microbiol. 303, 51-60 (2013).
38. Zetsche, B. et al. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 163, 759-771 (2015).
39. Dong, D. et al. The crystal structure of Cpf1 in complex with CRISPR RNA. Nature 532, 522-526 (2016).
40. Yamano, T. et al. Crystal structure of Cpf1 in complex with guide RNA and target DNA. Cell 165, 949-962 (2016).
41. Fonfara, I., Richter, H., Bratovic, M., Le Rhun, A. & Charpentier, E. The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA. Nature 532, 517-521 (2016).
42. Abudayyeh, O. O. et al. C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science 353, aaf5573 (2016).
43. Pasternak, C. et al. ISDra2 transposition in Deinococcus radiodurans is downregulated by TnpB. Mol. Microbiol. 88, 443-455 (2013).
44. Bao, W. & Jurka, J. Homologues of bacterial TnpB-IS605 are widespread in diverse eukaryotic transposable elements. Mob. DNA 4, 12 (2013).
45. Kapitonov, V. V., Makarova, K. S. & Koonin, E. V. ISC, a novel group of bacterial and archaeal DNA transposons that encode Cas9 homologs. J. Bacteriol. 198, 797-807 (2015).
46. Gomes-Filho, J. V. et al. Sense overlapping transcripts in IS1341?type transposase genes are functional non-coding RNAs in archaea. RNA Biol. 12, 490-500 (2015).
47. Westra, E. R., Buckling, A. & Fineran, P. C. CRISPR-Cas systems: beyond adaptive immunity. Nat. Rev. Microbiol. 12, 317-326 (2014).
48. Anantharaman, V., Makarova, K. S., Burroughs, A. M., Koonin, E. V. & Aravind, L. Comprehensive analysis of the HEPN superfamily: identification of novel roles in intra-genomic conflicts, defense, pathogenesis and RNA processing. Biol. Direct 8, 15 (2013).
49. Makarova, K. S., Anantharaman, V., Grishin, N. V., Koonin, E. V. & Aravind, L. CARF and WYL domains: ligand-binding regulators of prokaryotic defense systems. Front. Genet. 5, 102 (2014).
50. Makarova, K. S., Anantharaman, V., Aravind, L. & Koonin, E. V. Live virus-free or die: coupling of antivirus immunity and programmed suicide or dormancy in prokaryotes. Biol. Direct 7, 40 (2012).
51. Iranzo, J., Lobkovsky, A. E., Wolf, Y. I. & Koonin, E. V. Immunity, suicide or both? Ecological determinants for the combined evolution of anti-pathogen defense systems. BMC Evol. Biol. 15, 43 (2015).
52. East-Seletsky, A. et al. Two distinct RNase activities of CRISPR?C2c2 enable guide-RNA processing and RNA detection. Nature 538, 270-273 (2016).
53. Koonin, E. V., Dolja, V. V. & Krupovic, M. Origins and evolution of viruses of eukaryotes: the ultimate modularity. Virology 479-480, 2-25 (2015).
54. Sheppard, N. F., Glover, C. V., Terns, R. M. & Terns, M. P. The CRISPR-associated Csx1 protein of Pyrococcus furiosus is an adenosine-specific endoribonuclease. RNA 22, 216-224 (2016).
55. Niewoehner, O. & Jinek, M. Structural basis for the endoribonuclease activity of the type III?A CRISPRassociated protein Csm6. RNA 22, 318-329 (2016).
56. Curtis, T. P., Sloan, W. T. & Scannell, J. W. Estimating prokaryotic diversity and its limits. Proc. Natl Acad. Sci. USA 99, 10494-10499 (2002).
57. Curtis, T. P. et al. What is the extent of prokaryotic diversity? Philos. Trans. R. Soc. Lond. B Biol. Sci. 361, 2023-2037 (2006).
58. Fraser, C., Alm, E. J., Polz, M. F., Spratt, B. G. & Hanage, W. P. The bacterial species challenge: making sense of genetic and ecological diversity. Science 323, 741-746 (2009).
59. Quince, C., Curtis, T. P. & Sloan, W. T. The rational exploration of microbial diversity. ISME J. 2, 997-1006 (2008).
60. Chavez, A. et al. Comparison of Cas9 activators in multiple species. Nat. Methods 13, 563-567 (2016).
61. Thakore, P. I., Black, J. B., Hilton, I. B. & Gersbach, C. A. Editing the epigenome: technologies for programmable transcription and epigenetic modulation. Nat. Methods 13, 127-137 (2016).
62. Chen, B. et al. Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system. Cell 155, 1479-1491 (2013).
63. Knight, S. C. et al. Dynamics of CRISPR-Cas9 genome interrogation in living cells. Science 350, 823-826 (2015).
64. Nelles, D. A. et al. Programmable RNA tracking in live cells with CRISPR/Cas9. Cell 165, 488-496 (2016).
65. Hsu, P. D., Lander, E. S. & Zhang, F. Development and applications of CRISPR-Cas9 for genome engineering. Cell 157, 1262-1278 (2014).
66. Kleinstiver, B. P. et al. Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells. Nat. Biotechnol. 34, 869-874 (2016).
67. Kim, Y. et al. Generation of knockout mice by Cpf1?mediated gene targeting. Nat. Biotechnol. 34, 808-810 (2016).
68. Hur, J. K. et al. Targeted mutagenesis in mice by electroporation of Cpf1 ribonucleoproteins. Nat. Biotechnol. 34, 807-808 (2016).
69. Kim, D. et al. Genome-wide analysis reveals specificities of Cpf1 endonucleases in human cells. Nat. Biotechnol. 34, 863-868 (2016).
70. Li, S. Y., Zhao, G. P. & Wang, J. C?Brick: a new standard for assembly of biological parts using Cpf1. ACS Synth. Biol. http://dx.doi.org/10.1021/ acssynbio.6b00114 (2016).
71. O'Connell, M. R. et al. Programmable RNA recognition and cleavage by CRISPR/Cas9. Nature 516, 263-266 (2014).
72. Edgar, R. C. PILER?CR: fast and accurate identification of CRISPR repeats. BMC Bioinformatics 8, 18 (2007).
73. Grissa, I., Vergnaud, G. & Pourcel, C. CRISPRFinder: a web tool to identify clustered regularly interspaced short palindromic repeats. Nucleic Acids Res. 35, W52-W57 (2007).
74. Almendros, C., Guzman, N. M., Garcia-Martinez, J. & Mojica, F. J. Anti-cas spacers in orphan CRISPR4 arrays prevent uptake of active CRISPR-Cas I?F systems. Nat. Microbiol. 1, 16081 (2016).
75. Makarova, K. S., Wolf, Y. I. & Koonin, E. V. Comparative genomics of defense systems in archaea and bacteria. Nucleic Acids Res. 41, 4360-4377 (2013).
76. Liu, L. et al. C2c1-sgRNA complex structure reveals RNA-guided DNA cleavage mechanism. Mol. Cell http://dx.doi.org/10.1016/j.molcel.2016.11.040 (2016).
77. Yang, H., Gao, P., Rajashankar, K. R. & Patel, D. J. PAM-dependent target DNA recognition and cleavage by C2c1 CRISPR-Cas endonuclease. Cell 167, 1814-1828.e12 (2016).
78. Liu, L. et al. Two distant catalytic sites are responsible for C2c2 RNase activities. Cell 168, 121-134.e12 (2017).
79. Smargon, A. A. et al. Cas13b is a type VI-B CRISPRassociated RNA-guided RNase differentially regulated by accessory proteins Csx27 and Csx28. Mol. Cell http://dx.doi.org/10.1016/j.molcel.2016.12.023 (2017).
80. Burstein, D. et al. New CRISPR-Cas systems from uncultivated microbes. Nature http://dx.doi. org/10.1038/nature21059 (2016).